Corning Stock’s AI Surge: After The Meta Blockbuster, Is GLW Still A Buy?

The concern is this: UNH’s adjusted medical care ratio of 88.9% indicates they are disbursing $0.89 of every premium dollar for medical claims...

The reason? CVS is more diversified—they operate retail pharmacies (9,000 locations), Pharmacy Benefit Management (CVS Caremark with 87M members)...

The company's market capitalization has escalated by roughly $173 billion during the last 5 days and now sits at $1.7 trillion.

That 91.1% benefit ratio is harsh. For context, anything above 90% offers very scant opportunities for profitability.

Is this weakness merely temporary, or does it signal more profound issues in the business?

Let us examine some statistics and see how this payout ability measures up against the leading capital-return performers in the market.

Keytruda SC Approval: The FDA approved Keytruda QLEX (SC) in Sep/Oct 2025 for solid tumors, improving convenience.